A Randomised Phase 3 Study Evaluating Cystectomy with Perioperative Pembrolizumab and Cystectomy with Perioperative Enfortumab Vedotin and Pembrolizumab versus Cystectomy Alone in Cisplatin-Ineligible Participants with Muscle-Invasive Bladder Cancer (KEYNOTE-905/EV-303)

Project: Research

Project Details

StatusActive
Effective start/end date27/09/1926/09/24

Keywords

  • clinical trial
  • treatment safety
  • treatment efficacy
  • Bladder Cancer